Skip to main content
H.R. 1780 118th Congress House

Finn Sawyer Access to Cancer Testing Act

Official title: To facilitate the development of treatments for cancer, and for other purposes.

Introduced: March 24, 2023 Introduced by: Gus M. Bilirakis Republican · Florida See on congress.gov
Health CancerHealth care costs and insuranceHealth care coverage and accessHealth promotion and preventive care
More subjectsShow fewer subjects
MedicaidMedical tests and diagnostic methodsMedicarePoverty and welfare assistanceState and local government operations
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 17, 2024
Referred to the Subcommittee on Health.
Mar 31, 2023
Referred to the Subcommittee on Health.
Mar 24, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 24, 2023
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action December 17, 2024

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Finn Sawyer Access to Cancer Testing Act

This bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer.

Additionally, the Department of Health and Human Services must establish an education and awareness program for physicians and the public about genomic testing and the role of genetic counselors.

 Related & companion bills 1
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
 Lobbying activity 2

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

  • EXACT SCIENCES
    for EXACT SCIENCES · Wisconsin · 4th Quarter 2025 (Oct 1 - Dec 31)
  • EXACT SCIENCES
    for EXACT SCIENCES · Wisconsin · 3rd Quarter 2025 (July 1 - Sep 30)

Bodies those filers lobbied

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.

Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 1780: Finn Sawyer Access to Cancer Testing Act. 118th Congress. Open America. https://openamerica.io/bill/118-HR-1780/
MLA
"H.R. 1780: Finn Sawyer Access to Cancer Testing Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-1780/.
Bluebook (legal)
H.R. 1780, 118th Cong. (2026), https://openamerica.io/bill/118-HR-1780/.
Markdown link
[H.R. 1780: Finn Sawyer Access to Cancer Testing Act](https://openamerica.io/bill/118-HR-1780/)
Report a problem